Steinberg BA, Deering TF, Holubkov R, et al. Expedited Loading with Intravenous Sotalol and Mobile ECG Monitoring – Primary Results of the Prospective Evaluation Analysis and Kinetics of IV Sotalol (PEAKS) Registry. Poster Presented at Heart Rhythm Society 2023; May 19 -21, 2023; New Orleans, LA.
Liu AY, Charron J, Fugaro D, et al. Implementation of an intravenous sotalol initiation protocol: Implications for feasibility, safety, and length of stay. J Cardiovasc Electrophysiol. 2023; 34:502‐506.
Feuerborn ML, Dechand J, Vadlamudi RS, et al. Protocol Development and Initial Experience With Intravenous Sotalol Loading for Atrial Arrhythmias. Crit Pathw Cardiol. 2023 Mar 1;22(1):1-4.
Varela DL, Burnham TS, May H, et al. Economics and outcomes of sotalol in‐patient dosing approaches in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2022; 33:333-342. Electrophysiol. 2022;33:333‐342
Somberg J, Vinks A, Dong M, Molnar J. Model-Informed Development of Sotalol Loading and Dose Escalation Employing an Intravenous Infusion. Cardiology Research, North America, 11, Aug 2020
Badani, H., Seo, B. W., & Peyerl, F. W. (2019). PCV21 pharmacoeconomic analysis of sotalol loading: Comparison of 1-day inpatient loading of IV SOTALOL compared to the standard 3-Day loading protocol. Value in Health, 22. https://doi.org/10.1016/j.jval.2019.04.457
deSouza IS, Martindale JL, Sinert R. Antidysrhythmic drug therapy for the termination of stable, monomorphic ventricular tachycardia: a systemic review. Emerg Med J. 2015;32(2):161-167. Doi:10.1136/emermed-2013-202973
Somberg JC, Preston RA, Ranade V, Molnar J. Developing a safe intravenous sotalol dosing regimen. Am J Ther. 2010;17(4):365-372. Doi:10.1097/MJT.0b013e3181ea3184
AltaThera’s team met with many healthcare professionals interested in our product, and information was presented on Sotalol IV.
AltaThera partners with the Alliance of Cardiovascular Professionals to share information about Sotalol IV.
Sotalol IV is now approved for 1-day hospital outpatient initiation of AFib therapy and faster dose escalations for existing patients
AltaThera Pharmaceuticals has recently partnered with Rush University Medical Center to support arrhythmia research around the world.
AltaThera has donated vials of IV sotalol to the Veterinary Program at the University of Pennsylvania to better understand heart arrhythmias in dogs.
Patent No. US 11,696,902 B2
Patent No. US 11,610,660 B1
Patent No. US 11,344,518 B2
Patent No. US 10,512,620 B1
AltaThera’s team met with many healthcare professionals interested in our product, and information was presented on Sotalol IV.
Patent No. US 11,696,902 B2
Steinberg BA, Deering TF, Holubkov R, et al. Expedited Loading with Intravenous Sotalol and Mobile ECG Monitoring – Primary Results of the Prospective Evaluation Analysis and Kinetics of IV Sotalol (PEAKS) Registry. Poster Presented at Heart Rhythm Society 2023; May 19 -21, 2023; New Orleans, LA.
Patent No. US 11,610,660 B1
Liu AY, Charron J, Fugaro D, et al. Implementation of an intravenous sotalol initiation protocol: Implications for feasibility, safety, and length of stay. J Cardiovasc Electrophysiol. 2023; 34:502‐506.
Feuerborn ML, Dechand J, Vadlamudi RS, et al. Protocol Development and Initial Experience With Intravenous Sotalol Loading for Atrial Arrhythmias. Crit Pathw Cardiol. 2023 Mar 1;22(1):1-4.
Patent No. US 11,344,518 B2
Varela DL, Burnham TS, May H, et al. Economics and outcomes of sotalol in‐patient dosing approaches in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2022; 33:333-342. Electrophysiol. 2022;33:333‐342
AltaThera partners with the Alliance of Cardiovascular Professionals to share information about Sotalol IV.
Somberg J, Vinks A, Dong M, Molnar J. Model-Informed Development of Sotalol Loading and Dose Escalation Employing an Intravenous Infusion. Cardiology Research, North America, 11, Aug 2020
Sotalol IV is now approved for 1-day hospital outpatient initiation of AFib therapy and faster dose escalations for existing patients
Patent No. US 10,512,620 B1
Badani, H., Seo, B. W., & Peyerl, F. W. (2019). PCV21 pharmacoeconomic analysis of sotalol loading: Comparison of 1-day inpatient loading of IV SOTALOL compared to the standard 3-Day loading protocol. Value in Health, 22. https://doi.org/10.1016/j.jval.2019.04.457
AltaThera Pharmaceuticals has recently partnered with Rush University Medical Center to support arrhythmia research around the world.
AltaThera has donated vials of IV sotalol to the Veterinary Program at the University of Pennsylvania to better understand heart arrhythmias in dogs.
deSouza IS, Martindale JL, Sinert R. Antidysrhythmic drug therapy for the termination of stable, monomorphic ventricular tachycardia: a systemic review. Emerg Med J. 2015;32(2):161-167. Doi:10.1136/emermed-2013-202973
Somberg JC, Preston RA, Ranade V, Molnar J. Developing a safe intravenous sotalol dosing regimen. Am J Ther. 2010;17(4):365-372. Doi:10.1097/MJT.0b013e3181ea3184
